Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion

Molecular Cancer

Volumn 8, Issue , 2009, Pages

  Cheepala, Satish B ^a,b   Yin, Weihong ^a,c   Syed, Zanobia ^a   Gill, Jennifer N ^a   McMillian, Alaina ^a   Kleiner, Heather E ^a   Lynch, Mark ^d   Loganantharaj, Rasiah ^e   Trutschl, Marjan ^f   Cvek, Urska ^f   Clifford, John L ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d BAYER CORPORATION   (United States)

^e UNIVERSITY OF LOUISIANA AT LAFAYETTE   (United States)

^f LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MITOGEN ACTIVATED PROTEIN KINASE; RETINOIC ACID; SORAFENIB; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; CARCINOGEN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA MICROARRAY; DRUG TARGETING; ENZYME PHOSPHORYLATION; FEMALE; GENE ACTIVITY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; SKIN CARCINOMA; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR PROMOTION; UPREGULATION; ANIMAL; CELL TRANSFORMATION; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN TUMOR; WESTERN BLOTTING;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MAP KINASE KINASE KINASES; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS B-RAF; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRETINOIN;

EID: 66649094149     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-27     Document Type: Article

References (45)

1. Jemal A Siegel R Ward E Murray T Xu J Thun MJ Cancer statistics, 2007 CA Cancer J Clin 2007, 57:43-66 10.3322/canjclin.57.1.43 17237035
2. Alam M Ratner D Cutaneous squamous-cell carcinoma N Engl J Med 2001, 344:975-983 10.1056/NEJM200103293441306 11274625
3. Boukamp P Non-melanoma skin cancer: What drives tumor development and progression? Carcinogenesis 2005, 26:1657-1667 10.1093/carcin/bgi123 15905207
4. DiGiovanni J Multistage carcinogenesis in mouse skin Pharmacol Ther 1992, 54:63-128 10.1016/0163-7258(92)90051-Z 1528955
5. Zoumpourlis V Solakidi S Papathoma A Papaevangeliou D Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis Carcinogenesis 2003, 24:1159-1165 10.1093/carcin/bgg067 12807763
6. Chambon P A decade of molecular biology of retinoic acid receptors Faseb J 1996, 10:940-954 8801176
7. Lippman SM Lee JJ Sabichi AL Cancer chemoprevention: Progress and promise [see comments] J Natl Cancer Inst 1998, 90:1514-1528 10.1093/ jnci/90.20.1514 9790544
8. Chen L-C De Luca LM Retinoid effects on skin cancer Skin Cancer: Mechanisms and human relevance Boca Raton: CRC Press Mukhtar H 1994:401-424
9. Verma AK Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment Cancer Res 1987, 47:5097-5101 3621194
10. Angel P Szabowski A Schorpp-Kistner M Function and regulation of AP-1 subunits in skin physiology and pathology Oncogene 2001, 20:2413-2423 10.1038/sj.onc.1204380 11402337
11. Greenhalgh DA Welty DJ Player A Yuspa SH Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma Proc Natl Acad Sci USA 1990, 87:643-647 53321 2153961 10.1073/ pnas.87.2.643
12. Young MR Li JJ Rincon M Flavell RA Sathyanarayana BK Hunziker R Colburn N Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion Proc Natl Acad Sci USA 1999, 96:9827-9832 22295 10449779 10.1073/pnas.96.17.9827
13. Pfahl M Nuclear receptor/AP-1 interaction Endocr Rev 1993, 14:651-658 8262011
14. Huang C Ma WY Dawson MI Rincon M Flavell RA Dong Z Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid Proc Natl Acad Sci USA 1997, 94:5826-5830 20865 9159159 10.1073/ pnas.94.11.5826
15. Li JJ Dong Z Dawson MI Colburn NH Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element Cancer Res 1996, 56:483-489 8564958
16. Frost JA Geppert TD Cobb MH Feramisco JR A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum Proc Natl Acad Sci USA 1994, 91:3844-3848 43678 8170999 10.1073/pnas.91.9.3844
17. Watts RG Huang C Young MR Li JJ Dong Z Pennie WD Colburn NH Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation Oncogene 1998, 17:3493-3498 10.1038/sj.onc.1202259 10030673
18. Niles RM Signaling pathways in retinoid chemoprevention and treatment of cancer Mutat Res 2004, 555:81-96 15476854
19. Schena M Shalon D Davis RW Brown PO Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 1995, 270:467-470 10.1126/science.270.5235.467 7569999
20. Xu H Cheepala S McCauley E Coombes K Xiao L Fischer SM Clifford JL Chemoprevention of skin carcinogenesis by phenylretinamides: Retinoid receptor-independent tumor suppression Clin Cancer Res 2006, 12:969-979 10.1158/1078-0432.CCR-05-1648 16467112
21. Doniger SW Salomonis N Dahlquist KD Vranizan K Lawlor SC Conklin BR MAPPFinder: Using Gene Ontology And GenMAPP to create a global gene-expression profile from microarray data Genome Biology 2003, 4:R7 151291 12540299 10.1186/gb-2003-4-1-r7
22. Kamei Y Xu L Heinzel T Torchia J Kurokawa R Gloss B Lin SC Heyman RA Rose DW Glass CK Rosenfeld MG A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors Cell 1996, 85:403-414 10.1016/S0092-8674(00)81118-6 8616895
23. Harding A Tian T Westbury E Frische E Hancock JF Subcellular localization determines MAP kinase signal output Curr Biol 2005, 15:869-873 10.1016/j.cub.2005.04.020 15886107
24. Wilhelm SM Carter C Tang L Wilkie D McNabola A Rong H Chen C Zhang X Vincent P McHugh M et al BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis Cancer Res 2004, 64:7099-7109 10.1158/0008-5472.CAN-04-1443 15466206
25. Meyskens FL Studies of retinoids in the prevention and treatment of cancer J Am Acad Dermatol 1982, 6:824-827 10.1016/S0190-9622(82)70072-6 6950958
26. Levine N Miller RC Meyskens FL Jr Oral isotretinoin therapy. Use in a patient with multiple cutaneous squamous cell carcinomas and keratoacanthomas Arch Dermatol 1984, 120:1215-1217 10.1001/ archderm.120.9.1215 6591861
27. Moon TE Levine N Cartmel B Bangert JL Retinoids in prevention of skin cancer Cancer Lett 1997, 114:203-205 10.1016/S0304-3835(97)04663-6 9103292
28. Ridky TW Khavari PA Pathways sufficient to induce epidermal carcinogenesis Cell Cycle 2004, 3:621-624 15044848
29. Green CL Khavari PA Targets for molecular therapy of skin cancer Semin Cancer Biol 2004, 14:63-69 10.1016/j.semcancer.2003.11.007 14757536
30. Adams PD Parker PJ TPA-induced activation of MAP kinase FEBS Lett 1991, 290:77-82 10.1016/0014-5793(91)81230-6 1655537
31. Bild AH Yao G Chang JT Wang Q Potti A Chasse D Joshi MB Harpole D Lancaster JM Berchuck A et al Oncogenic pathway signatures in human cancers as a guide to targeted therapies Nature 2006, 439:353-357 10.1038/nature04296 16273092
32. Eferl R Wagner EF AP-1: A double-edged sword in tumorigenesis Nat Rev Cancer 2003, 3:859-868 10.1038/nrc1209 14668816
33. Benkoussa M Brand C Delmotte MH Formstecher P Lefebvre P Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter Mol Cell Biol 2002, 22:4522-4534 133906 12052862 10.1128/ MCB.22.13.4522-4534.2002
34. Smith ER Smedberg JL Rula ME Xu XX Regulation of Ras-MAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells J Cell Biol 2004, 164:689-699 2172165 14981092 10.1083/jcb.200312028
35. Chu BY Tran K Ku TK Crowe DL Regulation of ERK1 gene expression by coactivator proteins Biochem J 2005, 392:589-599 1316299 16050810 10.1042/BJ20050542
36. Dedieu S Lefebvre P Retinoids interfere with the AP1 signalling pathway in human breast cancer cells Cell Signal 2006, 18:889-898 10.1016/ j.cellsig.2005.08.001 16176868
37. Sah JF Eckert RL Chandraratna RA Rorke EA Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation J Biol Chem 2002, 277:9728-9735 10.1074/jbc.M110897200 11788593
38. Song S Lippman SM Zou Y Ye X Ajani JA Xu XC Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression Oncogene 2005, 24:8268-8276 10.1038/sj.onc.1208992 16170369
39. Dhillon AS Hagan S Rath O Kolch W MAP kinase signalling pathways in cancer Oncogene 2007, 26:3279-3290 10.1038/sj.onc.1210421 17496922
40. Tennenbaum T Lowry D Darwiche N Morgan DL Gartsbein M Hansen L De Luca LM Hennings H Yuspa SH Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion Cancer Res 1998, 58:1435-1443 9537245
41. Schlingemann J Hess J Wrobel G Breitenbach U Gebhardt C Steinlein P Kramer H Furstenberger G Hahn M Angel P Lichter P Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells Int J Cancer 2003, 104:699-708 10.1002/ijc.11008 12640676
42. Hummerich L Muller R Hess J Kokocinski F Hahn M Furstenberger G Mauch C Lichter P Angel P Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development Oncogene 2006, 25:111-121 16247483
43. Dooley TP Reddy SP Wilborn TW Davis RL Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR Biochem Biophys Res Commun 2003, 306:1026-1036 10.1016/S0006-291X(03)01099-4 12821146
44. Haider AS Peters SB Kaporis H Cardinale I Fei J Ott J Blumenberg M Bowcock AM Krueger JG Carucci JA Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia J Invest Dermatol 2006, 126:869-881 10.1038/sj.jid.5700157 16470182
45. Hansen LA Sigman CC Andreola F Ross SA Kelloff GJ De Luca LM Retinoids in chemoprevention and differentiation therapy Carcinogenesis 2000, 21:1271-1279 10.1093/carcin/21.7.1271 10874003